ALLMedicine™ Bone Tumors Center

Jun 23rd, 2022 - The advances of molecular techniques have led to the refinement of the classification of mesenchymal tumors, leading to newly introduced entities in the recently published fifth edition of the WHO Classification of Soft Tissue and Bone Tumors, whi...

Jun 21st, 2022 - Practice Essentials Primary bone lymphoma (PBL) is a rare, malignant, neoplastic disorder of the skeleton. In 1939, it was described as a distinct clinical condition by Parker and Jackson. [1] Later that year, Ewing included it among the bone tumo...

Jun 21st, 2022 - Practice Essentials Primary bone lymphoma (PBL) is a rare, malignant, neoplastic disorder of the skeleton. In 1939, it was described as a distinct clinical condition by Parker and Jackson. [1] Later that year, Ewing included it among the bone tumo...

Jun 21st, 2022 - Primary bone lymphoma (PBL) is a rare, malignant, neoplastic disorder of the skeleton. In 1939, it was described as a distinct clinical condition by Parker and Jackson.[1] Later that year, Ewing included it among the bone tumors listed in the Bone...

Jun 12th, 2022 - Cinobufagin (Huachansu), an aqueous extract from the dried skin of the toad Bufo bufo gargarizans Cantor (frog skin), is a biologically active ingredient of a traditional Chinese medicine cinobufacini that can treat multiple bone pathological cond...

May 7th, 2020 - Although primary bone tumors are relatively uncommon, appropriate imaging evaluation is essential when they are suspected or incidentally detected. In almost all cases, radiographs are the most appropriate initial imaging study for screening and c...

May 27th, 2022 - The scope of the project is to cover the entire population of children, adolescents and young adults from the age of 2 to the age of 21, who progressed to first-line treatment or who presented with a recurrence of Ewing's sarcoma or osteosarcoma. ...

May 19th, 2022 - Osteoid osteomas are painful, benign bone tumors that occur most frequently in young males between ages 10 and 20 years. The goal of the proposed study is based on the premise that MRgFUS is noninferior to CT-guided radiofrequency ablation (CTgRFA...

May 18th, 2022 - For this project, adult patients (>40 years) undergoing lumbar spinal fusion will be randomized to undergo teriparatide treatment for 1 month prior to surgery. Patients will have their baseline BMD assessed by DEXA scan must be considered as osteo...

Apr 5th, 2022 - In Italy, the incidence of primary bone tumors is around 0.8-1 case per 100,000 inhabitants, therefore an estimated 500 new cases of primary malignant bone tumors are estimated each year, affecting more frequently in children and young people. The...

Mar 29th, 2022 - Patients are usually considered for directed therapy (radiotherapy and/or surgery and/or thermo-ablation) in case of symptomatic lesions or at high risk of local complications. They also usually receive systemic bone-directed agents (bisphosphonat...

Jun 8th, 2022 - Young people with sarcoma may be at heightened risk for long-term opioid use following their cancer treatment. In a nationally representative cohort of adolescents and young adults with sarcoma, nearly two thirds took opioids during treatment, and...

Oct 6th, 2021 - The advent of 3D printing has led to an exciting revolution in limb salvage surgery for patients with bone tumors and soft tissue sarcomas, and have resulted in more precise resection and high-fidelity reconstruction, according to R. Lor Randall, ...

Oct 6th, 2021 - Jonathan C. Trent, MD, PhD Soft tissue sarcoma treatments have significantly advanced within the past year with new available agents, others in the pipeline, and the continued search for biomarkers to make treatment more personalized for patients...

Mar 19th, 2021 - NEW YORK (Reuters Health) - Radiofrequency ablation (RFA) for the palliative treatment of patients whose cancer has spread to the bone provides rapid and sustained pain relief and improves quality of life, according to new research. Radiation trea...

Dec 5th, 2020 - Christopher Parker, MD (right), speaking with a patient. An updated analysis of the results of a phase III clinical trial showed that radium-223 dichloride (Xofigo) significantly improved overall survival (OS) and delayed time to the first skelet...